Advances in mRNA & LNP Technology for In Vivo CAR-T Therapy

Session information

Availability

On demand

Host

Xtalks / GenScript

Access & registration

Free on-demand access; registration may be required.

On-demand, 60-minute webinar with GenScript's Mark Shulewitz on CAR constructs, RNA design and T-cell-targeted LNP approaches. It introduces platform concepts and supplier-described technologies; the listing does not treat these as proof of clinical efficacy or safety. Host: Xtalks / GenScript.